A UWS developed biotechnology has been recognised in an article published in the May/June edition of Life Scientist. Titled “Biotech spotlight: big deals”, the article highlights a select group of biotechnology companies to watch in the year ahead. In the article, Western Australian company Bio-Gene Technology Ltd is mentioned for its development of Qcide, a revolutionary natural insecticide. Developed as part of a research collaboration between UWS, Southern Cross University (SCU) and Bioprospect Ltd, the intellectual property has been assigned exclusively to Bio-Gene Technology, which has worldwide rights to the technology.Qcide is being developed as a new, environmentally friendly treatment for household and agricultural pests. The technology is based on Tasmanone, a natural insecticide derived from the leaves of Eucalyptus cloeziana, a forest tree species found in areas of Queensland. The active molecule exhibits a unique mode of action thought to be targeting the octopermine receptor in insects. This has been identified as the basis for a patenting and for commercialisation of the compound as an insecticide with applications in urban pest control, crop protection and animal health.
Bio-Gene believes that Qcide has the potential to make significant inroads into the global marketplace, where it will offer a greener alternative to established products such as additives required now to combat pyrethrum resistance. Pyrethrum which has a global market currently valued at US$500 million a year.
We encourage you to watch this space for future developments of this exciting technology.If you have any inquiries about harnessing UWS research for your business, please contact UWS Innovation & Consulting on (02) 9685 9742 or by email at ip@uws.edu.au
No comments:
Post a Comment